Affordable Access

deepdyve-link
Publisher Website

Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.

Authors
  • Chéret, Antoine
  • Nembot, Georges
  • Mélard, Adeline
  • Lascoux, Caroline
  • Slama, Laurence
  • Miailhes, Patrick
  • Yeni, Patrick
  • Abel, Sylvie
  • Avettand-Fenoel, Véronique
  • Venet, Alain
  • Chaix, Marie-Laure
  • Molina, Jean-Michel
  • Katlama, Christine
  • Goujard, Cécile
  • Tamalet, Catherine
  • Raffi, François
  • Lafeuillade, Alain
  • Reynes, Jacques
  • Ravaux, Isabelle
  • Hoën, Bruno
  • And 4 more
Type
Published Article
Journal
Osteoarthritis and Cartilage
Publisher
Elsevier
Publication Date
April 2015
Volume
15
Issue
4
Pages
387–396
Identifiers
DOI: 10.1016/S1473-3099(15)70021-6
PMID: 25701561
Source
USPC - SET - SVS
License
Unknown

Abstract

Inserm-ANRS, Gilead Sciences, Janssen Pharmaceuticals, Merck, and ViiV Laboratories.

Report this publication

Statistics

Seen <100 times